Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 1
1967 2
1968 4
1969 1
1970 1
1971 3
1972 2
1973 5
1974 2
1975 1
1976 2
1977 1
1978 6
1979 2
1981 3
1982 3
1983 1
1984 1
1985 2
1986 7
1987 6
1988 3
1989 1
1990 1
1991 5
1993 2
1994 1
1995 1
1996 1
1997 4
1998 2
1999 3
2000 3
2001 2
2002 8
2003 7
2004 7
2005 1
2006 4
2007 6
2008 13
2009 7
2010 7
2011 11
2012 6
2013 12
2014 5
2015 4
2016 9
2017 11
2018 4
2019 3
2020 4
2021 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
[Treatment of relapses of multiple sclerosis (a review)].
Brkovich RR, Totolian NA, Sokolov AIu, Ignatov IuD, Skoromets AA. Brkovich RR, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10 Pt 2):69-77. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 24416811 Review. Russian.
[Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study].
Shvartsman GI, Skoromets AA, Zhivolupov SA, Kurushina OV, Karpov SM, Baranova NS, Nesterova MV, Smagina IV, Prokopenko SV, Antipenko EA, Novikova LB. Shvartsman GI, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(8):88-94. doi: 10.17116/jnevro202212208188. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36036408 Russian.
[The biomarkers of cerebral ischemia as a new method for the validation of the efficacy of cytoprotective therapy].
Dambinova SA, Aliev KT, Bondarenko EV, Ponomarev GV, Skoromets AA, Skoromets AP, Skoromets TA, Smolko DG, Shumilina MV. Dambinova SA, et al. Among authors: skoromets ap, skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):62-67. doi: 10.17116/jnevro20171175162-67. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28638033 Russian.
Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
Marciniak C, McAllister P, Walker H, Brashear A, Edgley S, Deltombe T, Khatkova S, Banach M, Gul F, Vilain C, Picaut P, Grandoulier AS, Gracies JM; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Marciniak C, et al. PM R. 2017 Dec;9(12):1181-1190. doi: 10.1016/j.pmrj.2017.06.007. Epub 2017 Jun 16. PM R. 2017. PMID: 28625615 Free article. Clinical Trial.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi G, Kappos L, Olsson TP, Truffinet P, Wang L, Miller A, Freedman MS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group. Wolinsky JS, et al. Mult Scler. 2013 Sep;19(10):1310-9. doi: 10.1177/1352458513475723. Epub 2013 Feb 27. Mult Scler. 2013. PMID: 23447359 Free article. Clinical Trial.
216 results